Regulus Therapeutics Inc. sell StockNews.com
Start price
10.05.25
/
50%
€7.25
Target price
10.05.26
-
Performance (%)
-2.76%
End price
11.05.26
-
Summary
This prediction is currently being closed. With a performance of -2.76%, the SELL prediction for Regulus Therapeutics Inc. by StockNews_com is down slightly. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2.334% | 1.011% | 10.406% |
| iShares Nasdaq 100 | 1.370% | -3.612% | 27.400% |
| iShares Nikkei 225® | 2.437% | -7.461% | 49.840% |
| iShares S&P 500 | 1.259% | 0.677% | 23.666% |
Comments by StockNews_com for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.00
18.05.25
18.05.25
-
18.05.26
18.05.26
0.00%
19.05.26
19.05.26
